Recommendation for 74-Year-Old Woman with Bilateral Circumscribed Masses and New Breast Pain
This patient requires targeted breast ultrasound to evaluate the painful area, but the bilateral circumscribed masses themselves are benign and require only annual follow-up—breast pain alone does not warrant biopsy of these masses. 1
Clinical Context and Imaging Approach
The presence of multiple bilateral circumscribed masses with benign appearance on mammography represents a specific benign entity that does not require recall imaging or biopsy. Research demonstrates that multiple bilateral similar-appearing circumscribed masses have an extremely low malignancy rate of 0% in prospective studies 2, with interval cancer rates (0.14%) actually lower than age-matched population rates (0.24%) 3. More recent data from 2022 confirms 0% malignancy rate even for new or enlarging oval circumscribed parallel masses in this setting 4.
However, the new symptom of breast pain changes the clinical scenario and requires additional evaluation to establish concordance between symptoms and imaging findings 1.
Recommended Management Algorithm
Step 1: Targeted Ultrasound of Painful Area
- Perform diagnostic ultrasound specifically directed at the site of pain 1
- The goal is to determine if there is a correlate for the pain and to exclude any suspicious features not visible on mammography
- Mammography sensitivity is only 86-91% for palpable/symptomatic abnormalities 1
- The negative predictive value of mammography with ultrasound for symptomatic findings is 97.4-100% 1
Step 2: Interpretation Based on Ultrasound Findings
If ultrasound shows:
Simple cysts or definitively benign findings: Clinical follow-up only; pain management as needed 1
Solid masses with benign features (oval/round, circumscribed, parallel orientation, homogeneous) that match the bilateral pattern: Annual follow-up acceptable if concordant with clinical exam 1
- Cancer incidence in probably benign palpable masses is 0-2.0% when properly classified 1
Any suspicious features (irregular margins, posterior shadowing, non-parallel orientation) OR a mass that differs from the bilateral pattern: Image-guided core biopsy required 1
- Critical caveat: Three of four cancers found in patients with multiple bilateral circumscribed masses were new irregular masses or masses that changed morphology 4
No sonographic correlate for pain: The pain is likely non-breast-related (musculoskeletal, chest wall) and requires clinical management 5
Step 3: Management of the Bilateral Masses
The bilateral circumscribed masses themselves should be classified as benign (BI-RADS 2) and managed with annual screening mammography 6, 2, 3. These do not require:
Critical Pitfalls to Avoid
Do not biopsy the bilateral circumscribed masses based on pain alone—breast pain is overwhelmingly benign and does not correlate with malignancy in the setting of benign-appearing bilateral masses 5
Never allow negative imaging to override a highly suspicious clinical finding—if physical examination reveals a discrete, firm, fixed mass with skin changes, biopsy is mandatory regardless of imaging 1
Watch for the "unique finding"—any mass that differs morphologically from the bilateral pattern (irregular, spiculated, or with suspicious features) requires biopsy even in the setting of multiple bilateral masses 4
Ensure true concordance—the radiologist must personally confirm that any identified mass corresponds to the patient's area of pain 1
Pain Management Considerations
Since cyclical breast pain does not require imaging workup 5, determine if the pain is:
- Focal and persistent: Warrants the ultrasound approach described above
- Diffuse and cyclical: Supportive care without additional imaging
- Related to musculoskeletal causes: Clinical management without breast-specific imaging
The key principle: negative imaging should never override clinical suspicion, but in this case with benign-appearing bilateral masses and new pain, ultrasound evaluation of the painful area is the appropriate next step to establish concordance and exclude occult malignancy. 1